Oxford scientists are preparing to rapidly produce new versions of their vaccine to combat emerging more contagious Covid-19 variants discovered within the UK, South Africa and Brazil, The Telegraph has reported.
The team behind the vaccine from Oxford and AstraZeneca is undertaking feasibility studies to reconfigure the technology, the newspaper said on Wednesday, citing a confirmation from Oxford University .
The scientists were performing on estimating how quickly they might reconfigure their ChAdOx vaccine platform, the report said.
A university spokesman told the newspaper that Oxford is carefully assessing the impact of latest variants on vaccine immunity and evaluating the processes needed for rapid development of adjusted Covid-19 vaccines.
Oxford didn’t immediately answer a Reuters request for comment.
Separately, British Prime Minister Boris Johnson said on Wednesday that the country’s medicines regulator are going to be ready and ready to give approval to new versions of Covid-19 vaccines designed to counter new variants of the coronavirus which will appear.